These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

257 related articles for article (PubMed ID: 3768254)

  • 1. Steady-state pharmacokinetics and effects of a new once-daily, slow-release theophylline capsule preparation in asthma.
    Williams PE; Alwazir YA; Routledge PA; Campbell IA
    Br J Clin Pharmacol; 1986 Oct; 22(4):383-7. PubMed ID: 3768254
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Saliva and serum theophylline concentration in management of asthma in children on sustained-release therapy.
    Iwasaki E; Baba M
    J Asthma; 1987; 24(3):173-8. PubMed ID: 3505531
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of 12-hour and 24-hour sustained-release theophylline in outpatient management of asthma.
    Tilles DS; Hales CA
    Chest; 1987 Mar; 91(3):370-5. PubMed ID: 3816315
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A double-blind, placebo-controlled comparison of the efficacy of standard and individually titrated doses of theophylline in patients with chronic asthma.
    Barlow TJ; Graham P; Harris JM; Hartley JP; Turton CW
    Br J Dis Chest; 1988 Jul; 82(3):251-61. PubMed ID: 3073805
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The relationship between pharmacodynamics and pharmacokinetics in asthmatic children receiving a sustained-release formulation of theophylline.
    Schaefers M; Richter O; Reinhardt D; Becker B
    Int J Clin Pharmacol Ther Toxicol; 1984 Aug; 22(8):406-15. PubMed ID: 6490223
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Components of variability in serum theophylline concentrations during maintenance therapy with a sustained release formulation.
    Halkin H; Mazar A; Almog S; Schnaps Y
    Eur J Clin Pharmacol; 1982; 23(3):225-8. PubMed ID: 7173293
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluation of serum theophylline concentrations following administration of sustained-release beads in applesauce to asthmatic preschool children.
    Leeder JS; Robertson C; Correia J; Isles AF; Levison H; Macleod SM
    Ann Allergy; 1986 Feb; 56(2):133-7. PubMed ID: 3946845
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacokinetics and pharmacodynamics of three sustained-release theophylline preparations (Theograd, 350 mg Theolair Retard, and 300 mg Theolin Retard) in steady state in six normals and six patients with chronic asthmatic bronchitis--Part II: Lung function.
    van der Vet AP; Kreukniet J; Drost RH; Maes RA
    Int J Clin Pharmacol Ther Toxicol; 1985 Jul; 23(7):339-44. PubMed ID: 4030161
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Once-daily sustained-release theophylline reduces diurnal variation in spirometry and symptomatology in adult asthmatics.
    Arkinstall WW; Atkins ME; Harrison D; Stewart JH
    Am Rev Respir Dis; 1987 Feb; 135(2):316-21. PubMed ID: 3813191
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of a sustained-release preparation (Theo-Dur) with a conventional preparation (Nuelin) in the treatment of chronic asthma.
    Haahtela T; Vilkka V; Kulstad S
    Allergy; 1983 Nov; 38(8):589-92. PubMed ID: 6660438
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Theophylline concentrations in serum and saliva after oral microcrystalline and sustained-release preparations in asthmatics.
    Munch EP; Søndergaard I; Weeke B
    Allergy; 1981 Feb; 36(2):89-98. PubMed ID: 7235205
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Treatment of nocturnal asthma: the role of sustained-release theophylline and oral beta-2-mimetics.
    Wilkens JH; Wilkens H; Heins M; Kurtin L; Oellerich M; Sybrecht GW
    Chronobiol Int; 1987; 4(3):387-96. PubMed ID: 3315268
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A comparison of low-dose inhaled budesonide plus theophylline and high-dose inhaled budesonide for moderate asthma.
    Evans DJ; Taylor DA; Zetterstrom O; Chung KF; O'Connor BJ; Barnes PJ
    N Engl J Med; 1997 Nov; 337(20):1412-8. PubMed ID: 9358138
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Relationship between plasma and stimulated-saliva concentrations of theophylline in asthmatic children.
    Krivoy N; Zinman P; Hoffer E; Teitelman U; Rubin A
    Pharmatherapeutica; 1985; 4(5):285-7. PubMed ID: 4070321
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Controlled-release theophylline in the treatment of nocturnal asthma.
    Fairfax AJ; Clarke R; Chatterjee SS; Connolly CK; Higenbottam T; Holgate ST; Hughes JA; Johnson CE; Johnston RN; MacIntyre D
    J Int Med Res; 1990; 18(4):273-81. PubMed ID: 2227074
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Clinical effectiveness of a new preparation of sustained-release theophylline].
    Corrias A; Pelosi U; Corona GB; Burrai P; Corda R
    Pediatr Med Chir; 1989; 11(5):537-9. PubMed ID: 2631061
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Nocturnal asthma: effect of a once per evening dose of sustained release theophylline.
    Neuenkirchen H; Wilkens JH; Oellerich M; Sybrecht GW
    Eur J Respir Dis; 1985 Mar; 66(3):196-204. PubMed ID: 3884358
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of once-a-day and twice-a-day theophylline in asthma.
    Fairshter RD; Lowe JE; Wilson AF; Salness K; Novey HS
    Respiration; 1986; 50(3):193-201. PubMed ID: 3797827
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sustained release theophylline in nocturnal asthma.
    Elias-Jones AC; Higenbottam TW; Barnes ND; Godden DJ
    Arch Dis Child; 1984 Dec; 59(12):1159-61. PubMed ID: 6395810
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The effect of sustained-release theophylline in nocturnal asthma.
    Freeman W; Packe GE; Cayton RM
    Br J Clin Pract; 1991; 45(1):21-5. PubMed ID: 1931534
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.